Your browser doesn't support javascript.
loading
Practical use of the central venous access port for contrast-enhanced CT: comparison with peripheral intravenous access regarding enhancement and safety.
Washio, H; Kashimoto, K; Sakashita, N; Ohira, S; Tanaka, J; Maeda, N; Shimada, M; Kawamata, M; Yoneda, A; Nakanishi, K.
Afiliación
  • Washio H; Department of Diagnosis and Interventional Radiology, Osaka International Cancer Institute, Osaka, Japan. Electronic address: washio-ha@oici.jp.
  • Kashimoto K; Department of Diagnosis and Interventional Radiology, Osaka International Cancer Institute, Osaka, Japan.
  • Sakashita N; Department of Diagnosis and Interventional Radiology, Osaka International Cancer Institute, Osaka, Japan.
  • Ohira S; Department of Comprehensive Radiation Oncology, The University of Tokyo, Tokyo, Japan; Department of Radiation Oncology, Osaka International Cancer Institute, Osaka, Japan.
  • Tanaka J; Department of Diagnosis and Interventional Radiology, Osaka International Cancer Institute, Osaka, Japan.
  • Maeda N; Department of Diagnosis and Interventional Radiology, Osaka International Cancer Institute, Osaka, Japan.
  • Shimada M; Department of Diagnosis and Interventional Radiology, Osaka International Cancer Institute, Osaka, Japan.
  • Kawamata M; Department of Diagnosis and Interventional Radiology, Osaka International Cancer Institute, Osaka, Japan.
  • Yoneda A; Department of Diagnosis and Interventional Radiology, Osaka International Cancer Institute, Osaka, Japan.
  • Nakanishi K; Department of Diagnosis and Interventional Radiology, Osaka International Cancer Institute, Osaka, Japan.
Clin Radiol ; 79(3): 213-220, 2024 Mar.
Article en En | MEDLINE | ID: mdl-38218706
ABSTRACT

AIM:

To evaluate the efficacy of using the central venous (CV) port compared with peripheral intravenous access for contrast-material injection for contrast enhancement during the portal venous phase. MATERIALS AND

METHODS:

Patients were divided into three groups CV delay, CV routine, and peripheral access (PA) groups. Patients in the CV delay group underwent injection in the arm-down position with an additional delay, while those in the CV routine and PA groups underwent injections with the routine injection protocol for portal venous phase imaging. Contrast enhancement was evaluated by measuring the mean radiodensity (Hounsfield units) values for the aortic arch, abdominal aorta, inferior vena cava, portal vein, and spleen. The peak injection pressure was recorded and compared among the three groups.

RESULTS:

No complications related to power injection were observed during 119 contrast-material injections performed using the CV port device. The CV delay group showed significantly lower radiodensity values than the PA group (165.7 ± 20.1 versus 181 ± 19 HU [p<0.01] for the portal vein); however, no significant differences in mean radiodensity values were observed between the CV routine and PA groups (p>0.05). The median peak injection pressure was 73.5, 67, and 47 psi in the CV delay, CV routine, and PA groups, respectively (p<0.01).

CONCLUSION:

The CV port can be used for safe contrast-material injection while maintaining contrast enhancement on portal venous phase comparable to that achieved with peripheral intravenous access.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Cateterismo Venoso Central / Tomografía Computarizada por Rayos X Límite: Humans Idioma: En Revista: Clin Radiol Año: 2024 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Cateterismo Venoso Central / Tomografía Computarizada por Rayos X Límite: Humans Idioma: En Revista: Clin Radiol Año: 2024 Tipo del documento: Article
...